vs
Cytek Biosciences, Inc.（CTKB）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是REGIS CORP的1.1倍（$62.1M vs $57.1M），REGIS CORP净利率更高（0.8% vs -70.9%，领先71.7%），REGIS CORP同比增速更快（22.3% vs 8.1%），REGIS CORP自由现金流更多（$891.0K vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 7.8%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
CTKB vs RGS — 直观对比
营收规模更大
CTKB
是对方的1.1倍
$57.1M
营收增速更快
RGS
高出14.1%
8.1%
净利率更高
RGS
高出71.7%
-70.9%
自由现金流更多
RGS
多$2.7M
$-1.8M
两年增速更快
CTKB
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $57.1M |
| 净利润 | $-44.1M | $456.0K |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 10.8% |
| 净利率 | -70.9% | 0.8% |
| 营收同比 | 8.1% | 22.3% |
| 净利润同比 | -557.1% | -94.0% |
| 每股收益（稀释后） | — | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBRGS
| Q4 25 | $62.1M | $57.1M | ||
| Q3 25 | $52.3M | $59.0M | ||
| Q2 25 | $45.6M | $60.4M | ||
| Q1 25 | $41.5M | $57.0M | ||
| Q4 24 | $57.5M | $46.7M | ||
| Q3 24 | $51.5M | $46.1M | ||
| Q2 24 | $46.6M | $49.4M | ||
| Q1 24 | $44.9M | $49.2M |
净利润CTKBRGS
| Q4 25 | $-44.1M | $456.0K | ||
| Q3 25 | $-5.5M | $1.4M | ||
| Q2 25 | $-5.6M | $116.5M | ||
| Q1 25 | $-11.4M | $250.0K | ||
| Q4 24 | $9.6M | $7.6M | ||
| Q3 24 | $941.0K | $-853.0K | ||
| Q2 24 | $-10.4M | $91.2M | ||
| Q1 24 | $-6.2M | $-2.3M |
毛利率CTKBRGS
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBRGS
| Q4 25 | -9.0% | 10.8% | ||
| Q3 25 | -17.6% | 10.0% | ||
| Q2 25 | -23.3% | 12.1% | ||
| Q1 25 | -36.1% | 8.8% | ||
| Q4 24 | 5.2% | 11.8% | ||
| Q3 24 | -8.2% | 4.6% | ||
| Q2 24 | -18.3% | — | ||
| Q1 24 | -23.9% | 8.3% |
净利率CTKBRGS
| Q4 25 | -70.9% | 0.8% | ||
| Q3 25 | -10.5% | 2.3% | ||
| Q2 25 | -12.2% | 192.9% | ||
| Q1 25 | -27.5% | 0.4% | ||
| Q4 24 | 16.8% | 16.4% | ||
| Q3 24 | 1.8% | -1.9% | ||
| Q2 24 | -22.4% | 184.7% | ||
| Q1 24 | -13.8% | -4.7% |
每股收益（稀释后）CTKBRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | — | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $341.7M | $188.7M |
| 总资产 | $461.5M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资CTKBRGS
| Q4 25 | $90.9M | $18.4M | ||
| Q3 25 | $93.3M | $16.6M | ||
| Q2 25 | $75.5M | $17.0M | ||
| Q1 25 | $95.3M | $13.3M | ||
| Q4 24 | $98.7M | $10.2M | ||
| Q3 24 | $162.3M | $6.3M | ||
| Q2 24 | $177.9M | $10.1M | ||
| Q1 24 | $168.8M | $5.9M |
总债务CTKBRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益CTKBRGS
| Q4 25 | $341.7M | $188.7M | ||
| Q3 25 | $378.6M | $187.6M | ||
| Q2 25 | $377.6M | $185.6M | ||
| Q1 25 | $379.6M | $68.6M | ||
| Q4 24 | $395.7M | $66.7M | ||
| Q3 24 | $385.5M | $56.4M | ||
| Q2 24 | $389.1M | $56.8M | ||
| Q1 24 | $392.6M | $-35.8M |
总资产CTKBRGS
| Q4 25 | $461.5M | $588.3M | ||
| Q3 25 | $494.9M | $592.1M | ||
| Q2 25 | $493.3M | $599.0M | ||
| Q1 25 | $482.6M | $511.2M | ||
| Q4 24 | $499.5M | $530.1M | ||
| Q3 24 | $491.2M | $508.9M | ||
| Q2 24 | $483.7M | $530.5M | ||
| Q1 24 | $492.1M | $543.7M |
负债/权益比CTKBRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $891.0K |
| 自由现金流率自由现金流/营收 | -2.9% | 1.6% |
| 资本支出强度资本支出/营收 | 1.6% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $14.9M |
8季度趋势，按日历期对齐
经营现金流CTKBRGS
| Q4 25 | $-771.0K | $1.7M | ||
| Q3 25 | $-3.9M | $2.3M | ||
| Q2 25 | $108.0K | $6.8M | ||
| Q1 25 | $-125.0K | $6.2M | ||
| Q4 24 | $2.0M | $2.1M | ||
| Q3 24 | $13.2M | $-1.3M | ||
| Q2 24 | $6.2M | $5.1M | ||
| Q1 24 | $4.0M | $-277.0K |
自由现金流CTKBRGS
| Q4 25 | $-1.8M | $891.0K | ||
| Q3 25 | $-4.6M | $1.9M | ||
| Q2 25 | $-1.5M | $6.2M | ||
| Q1 25 | $-974.0K | $5.9M | ||
| Q4 24 | $1.1M | $1.7M | ||
| Q3 24 | $12.2M | $-1.4M | ||
| Q2 24 | $5.2M | $5.1M | ||
| Q1 24 | $3.4M | $-326.0K |
自由现金流率CTKBRGS
| Q4 25 | -2.9% | 1.6% | ||
| Q3 25 | -8.7% | 3.2% | ||
| Q2 25 | -3.2% | 10.3% | ||
| Q1 25 | -2.3% | 10.3% | ||
| Q4 24 | 1.9% | 3.6% | ||
| Q3 24 | 23.7% | -3.0% | ||
| Q2 24 | 11.0% | 10.3% | ||
| Q1 24 | 7.6% | -0.7% |
资本支出强度CTKBRGS
| Q4 25 | 1.6% | 1.4% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 3.5% | 0.9% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 0.9% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.1% |
现金转化率CTKBRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | 0.21× | 0.28× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
